11/24
09:40 am
ctnm
Rating for CTNM
Low
Report
Rating for CTNM
11/24
09:40 am
ctnm
Rating for CTNM
Low
Report
Rating for CTNM
11/21
09:33 am
ctnm
Rating for CTNM
Low
Report
Rating for CTNM
11/21
09:33 am
ctnm
Rating for CTNM
Low
Report
Rating for CTNM
11/13
09:53 am
ctnm
Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $22.00 price target on the stock.
Medium
Report
Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $22.00 price target on the stock.